IRLAB Therapeutics AB (publ) (FRA:6IRA)

IRLAB Therapeutics AB Revenue

IRLAB Therapeutics AB had revenue of 18.85M SEK in the quarter ending September 30, 2025, with 108.69% growth. This brings the company's revenue in the last twelve months to 85.56M, up 69.03% year-over-year. In the year 2024, IRLAB Therapeutics AB had annual revenue of 94.63M with 1,566.57% growth.

• Revenue (ttm): 85.56M SEK
• Revenue Growth: +69.03%
• P/S Ratio: 1.89
• Revenue / Employee: 2.76M SEK
• Employees: 31
• Market Cap: 14.61M EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	94.63M	88.95M	1,566.57%
Dec 31, 2023	5.68M	-55.46M	-90.71%
Dec 31, 2022	61.14M	-146.65M	-70.58%
Dec 31, 2021	207.78M	207.48M	69,160.67%
Dec 31, 2020	300.00K	-72.00K	-19.35%